🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: A+C Vaccine

Found 889 matching trials

Safety and Immunogenicity Study of GSK's Clostridium Difficile Vaccine 2904545A When Administered in Healthy Adults Aged 18-45 Years and 50-70 Years

PHASE1

The purpose of this study is to generate safety, reactogenicity (assessment...

Status

Completed

Location

GSK Investigational Site

Start Date

2019-08-05

Trial ID

NCT04026009

Treatments Being Tested

C. difficile investigational vaccine based on the F2 antigen (GSK2904545A)C. difficile investigational vaccine based on the F2 antigen (GSK2904545A) adjuvanted with AS01B Placebo

Safety, Tolerability and Efficacy of PfSPZ Vaccine Against Heterologous CHMI in US Malaria naïve Adults

PHASE1

This is a randomized, double blind, placebo-controlled, single site, trial ...

Status

Completed

Location

Fred Hutchinson Cancer Research Center

Start Date

2021-09-27

Trial ID

NCT04966871

Treatments Being Tested

PfSPZ Vaccine PfSPZ Challenge (7G8) for CHMI Normal Saline

Study of a Novel Multicomponent Meningococcal Group B Vaccine When Given Alone or With Other Licensed Vaccines in Adults, Adolescents, Toddlers and Infants

PHASE1

Primary Objective: * To describe the safety profile of the SP MenB vaccine...

Status

Terminated

Location

Lakeview Clinical Research Site Number : 8400029

Start Date

2021-03-29

Trial ID

NCT04825223

Treatments Being Tested

Multicomponent Meningococcal B Vaccine Meningococcal Group B Vaccine MenB Meningococcal Group B Vaccine (recombinant deoxyribonucleic acid [rDNA], component, adsorbed)Placebo Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine MenACYW conjugate vaccine

Open Randomized Trial Evaluating Four Anti-pneumococcal Vaccine Strategies With Fractionated Doses of Non Conjugate Polysaccharide Vaccine to Prevent Hyporesponse in Healthy Volunteers

PHASE2

Immune response analysis after the combination of PCV13 and PPV23 will lead...

Status

Completed

Location

Multiple Locations

Start Date

2014-12-04

Trial ID

NCT02279589

Treatments Being Tested

Pneumo 23® 0,5 Pneumo 23® 0,1 Prevenar13® 0,5

Evaluating the Safety and Immunogenicity of Polyvalent DNA/gp120 HIV Vaccine in Healthy, HIV-uninfected Adults

PHASE1

The purpose of the study is to evaluate the safety, tolerability, and immun...

Status

Completed

Location

Brigham and Women's Hospital

Start Date

2021-07-08

Trial ID

NCT04927585

Treatments Being Tested

env (A,B,C,A/E)/gag (C) DNA Vaccine gp120 (A,B,C,A/E) Protein Vaccine GLA-SE adjuvant Placebo

A Study of SII Yellow Fever Vaccine to Compare Safety and Immunogenicity With STAMARIL® In Healthy Infants

PHASE3

The study is designed as a Phase III, double-blind, multi-center, randomize...

Status

Unknown

Location

Center for Vaccine Development

Start Date

2022-09-16

Trial ID

NCT05447377

Treatments Being Tested

SII Yellow Fever Vaccine STAMARIL®

Immunogenicity and Safety of Bivalent Meningococcal Serogroups A and C Tetanus Toxoid Conjugate Vaccine in Chinese

PHASE3

Invasive meningococcal disease and meningococcal meningitis caused by Neiss...

Status

Completed

Location

Multiple Locations

Start Date

2016-05-12

Trial ID

NCT03714737

Treatments Being Tested

experimental vaccine Positive control vaccine 1 Positive control vaccine 2

A Study on the Safety, Effectiveness and Immune Response of Meningococcal Combined ABCWY Vaccine in Healthy Adolescents and Adults

PHASE1

The purpose of this study was to assess the safety, effectiveness, and immu...

Status

Completed

Location

GSK Investigational Site

Start Date

2021-06-14

Trial ID

NCT04886154

Treatments Being Tested

MenABCWY-2Gen low dose vaccine MenABCWY-2Gen high dose vaccine Placebo MenB vaccine MenACWY vaccine

Comparison of GSKBiologicals' Hib-MenCY-TT Vaccine vs Licensed Hib Conjugate or Meningococcal Vaccine

PHASE2

This study is evaluating the safety and immunogenicity of GSK Biologicals' ...

Status

Completed

Location

GSK Investigational Site

Start Date

2004-08-01

Trial ID

NCT00129129

Treatments Being Tested

GSK Biologicals' Haemophilus influenza type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine 792014 vaccine ActHIB Pediarix Prevnar Menomune

A Randomized Phase I Study of a Hepatitis B Antigen Combined With IMP321

PHASE1

This is a single centre, three single administrations (Days 1, 29 and 57) a...

Status

Completed

Location

SGS Aster-Cephac

Start Date

2005-05

Trial ID

NCT00354861

Treatments Being Tested

hepatitis B antigen (without alum) plus IMP321 hepatitis B antigen alone (without alum)Engerix B

Previous Next